Search Results - "Whittles, Lilith K"

Refine Results
  1. 1

    Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study by Whittles, Lilith K, White, Peter J, Didelot, Xavier

    Published in PLoS medicine (31-10-2017)
    “…Gonorrhoea is one of the most common bacterial sexually transmitted infections in England. Over 41,000 cases were recorded in 2015, more than half of which…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A dynamic power-law sexual network model of gonorrhoea outbreaks by Whittles, Lilith K, White, Peter J, Didelot, Xavier

    Published in PLoS computational biology (01-03-2019)
    “…Human networks of sexual contacts are dynamic by nature, with partnerships forming and breaking continuously over time. Sexual behaviours are also highly…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Genomic Analysis and Comparison of Two Gonorrhea Outbreaks by Didelot, Xavier, Dordel, Janina, Whittles, Lilith K, Collins, Caitlin, Bilek, Nicole, Bishop, Cynthia J, White, Peter J, Aanensen, David M, Parkhill, Julian, Bentley, Stephen D, Spratt, Brian G, Harris, Simon R

    Published in mBio (28-06-2016)
    “…Gonorrhea is a sexually transmitted disease causing growing concern, with a substantial increase in reported incidence over the past few years in the United…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Epidemiological Trends of Antibiotic Resistant Gonorrhoea in the United Kingdom by Whittles, Lilith K, White, Peter J, Paul, John, Didelot, Xavier

    Published in Antibiotics (Basel) (13-07-2018)
    “…Gonorrhoea is one of the most common sexually-transmitted bacterial infections, globally and in the United Kingdom. The levels of antibiotic resistance in…”
    Get full text
    Journal Article
  10. 10

    Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis by Whittles, Lilith K, Didelot, Xavier, White, Peter J

    Published in The Lancet infectious diseases (01-07-2022)
    “…Gonorrhoea is a rapidly growing public health threat, with rising incidence and increasing drug resistance. Evidence that the MeNZB and four-component…”
    Get full text
    Journal Article
  11. 11

    Epidemiological analysis of the Eyam plague outbreak of 1665–1666 by Whittles, Lilith K., Didelot, Xavier

    “…Plague, caused by the bacterium Yersinia pestis, is one of the deadliest infectious diseases in human history, and still causes worrying outbreaks in Africa…”
    Get full text
    Journal Article
  12. 12

    Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics by Whittles, Lilith K, White, Peter J, Didelot, Xavier

    Published in Clinical infectious diseases (05-11-2020)
    “…Abstract Background Gonorrhea incidence is increasing rapidly in many countries, while antibiotic resistance is making treatment more difficult. Combined with…”
    Get full text
    Journal Article
  13. 13

    The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial by White, Peter J, Leng, Trystan, Nikitin, Dariya, Whittles, Lilith K

    Published in The Lancet infectious diseases (01-09-2024)
    “…On Nov 10, 2023, the Joint Committee on Vaccination and Immunisation advised the UK to use the 4CMenB meningitis B vaccine to prevent gonorrhoea in men who…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Health-Economic Value of Vaccination Against Group A Streptococcus in the United States by Andrejko, Kristin, Whittles, Lilith K, Lewnard, Joseph A

    Published in Clinical infectious diseases (23-03-2022)
    “…Abstract Background Vaccines are needed to reduce the burden of group A Streptococcus (GAS). We assessed the potential health-economic value of GAS vaccines…”
    Get full text
    Journal Article
  16. 16

    We need estimates of gonorrhoea vaccine protection and symptomaticity by sex and anatomical site by White, Peter J, Nikitin, Dariya, Whittles, Lilith K

    Published in The Lancet infectious diseases (01-07-2022)
    “…To make the best use of limited public health resources, we need to determine the appropriate groups to be offered gonorrhoea vaccination—eg, men who have sex…”
    Get full text
    Journal Article
  17. 17

    Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection by Nikitin, Dariya, Whittles, Lilith K, Imai-Eaton, Jeffrey W, White, Peter J

    Published in The Journal of infectious diseases (17-04-2024)
    “…Observational evidence suggests the 4CMenB meningococcal vaccine may partially protect against gonorrhea, with one dose being two-thirds as protective as two…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20